94 related articles for article (PubMed ID: 9615782)
1. Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms.
Serafino A; Sinibaldi-Vallebona P; Gaudiano G; Koch TH; Rasi G; Garaci E; Ravagnan G
Anticancer Res; 1998; 18(2A):1159-66. PubMed ID: 9615782
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering?
Serafino A; Sinibaldi-Vallebona P; Pierimarchi P; Bernard P; Gaudiano G; Massa C; Rasi G; Ranagnan G
Anticancer Res; 1999; 19(3A):1909-18. PubMed ID: 10470135
[TBL] [Abstract][Full Text] [Related]
3. Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/DOX cells. Inhibition of glutathione S-transferase p1-1 by glutathione conjugates from anthracyclines.
Gaudiano G; Koch TH; Lo Bello M; Nuccetelli M; Ravagnan G; Serafino A; Sinibaldi-Vallebona P
Biochem Pharmacol; 2000 Dec; 60(12):1915-23. PubMed ID: 11108808
[TBL] [Abstract][Full Text] [Related]
4. The nuclear membrane in multidrug resistance: microinjection of epirubicin into bladder cancer cell lines.
Featherstone JM; Speers AG; Lwaleed BA; Hayes MC; Cooper AJ; Birch BR
BJU Int; 2005 May; 95(7):1091-8. PubMed ID: 15839939
[TBL] [Abstract][Full Text] [Related]
5. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines.
Taatjes DJ; Fenick DJ; Koch TH
Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398
[TBL] [Abstract][Full Text] [Related]
6. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
8. Resistance to cisplatin and adriamycin is associated with the inhibition of glutathione efflux in MCF-7-derived cells.
Osbild S; Brault L; Battaglia E; Bagrel D
Anticancer Res; 2006; 26(5A):3595-600. PubMed ID: 17094488
[TBL] [Abstract][Full Text] [Related]
9. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
[TBL] [Abstract][Full Text] [Related]
10. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Majumder S; Dutta P; Mookerjee A; Choudhuri SK
Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity, accumulation, and intracellular distribution of anthracycline antibiotics and their conjugates with the epidermal growth factor in sensitive and resistant MCF-7 cells.
Lutsenko SV; Feldman NB; Gumanov SG; Rodina AV; Severin SE
Biochemistry (Mosc); 2000 Nov; 65(11):1299-304. PubMed ID: 11112847
[TBL] [Abstract][Full Text] [Related]
12. Circumvention of tumor multidrug resistance by a new annonaceous acetogenin: atemoyacin-B.
Fu LW; Pan QC; Liang YJ; Huang HB
Zhongguo Yao Li Xue Bao; 1999 May; 20(5):435-9. PubMed ID: 10678092
[TBL] [Abstract][Full Text] [Related]
13. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
14. Confocal scanning microspectrofluorometry reveals specific anthracyline accumulation in cytoplasmic organelles of multidrug-resistant cancer cells.
Belhoussine R; Morjani H; Millot JM; Sharonov S; Manfait M
J Histochem Cytochem; 1998 Dec; 46(12):1369-76. PubMed ID: 9815278
[TBL] [Abstract][Full Text] [Related]
15. [Internalization of antibody-targeted immunonanoparticles into human hepatoma cells and its reversal effect on MDR].
Liu X; Wang X; Wei D; Cai M; Li G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):431-4. PubMed ID: 12910681
[TBL] [Abstract][Full Text] [Related]
16. Anthracyclines.
Sinha BK; Politi PM
Cancer Chemother Biol Response Modif; 1990; 11():45-57. PubMed ID: 2223402
[TBL] [Abstract][Full Text] [Related]
17. Modifications of mitochondria in human tumor cells during anthracycline-induced apoptosis.
Serafino A; Sinibaldi-Vallebona P; Lazzarino G; Tavazzi B; Di Pierro D; Rasi G; Ravagnan G
Anticancer Res; 2000; 20(5B):3383-94. PubMed ID: 11131638
[TBL] [Abstract][Full Text] [Related]
18. The nitroxide Tempol modulates anthracycline resistance in breast cancer cells.
Gariboldi MB; Terni F; Ravizza R; Meschini S; Marra M; Condello M; Arancia G; Monti E
Free Radic Biol Med; 2006 Apr; 40(8):1409-18. PubMed ID: 16631531
[TBL] [Abstract][Full Text] [Related]
19. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
Jin J; Wang FP; Wei H; Liu G
Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274
[TBL] [Abstract][Full Text] [Related]
20. Intracellular P-glycoprotein in multidrug resistant tumor cells.
Arancia G; Molinari A; Calcabrini A; Meschini S; Cianfriglia M
Ital J Anat Embryol; 2001; 106(2 Suppl 1):59-68. PubMed ID: 11729998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]